AstraZeneca to resume coronavirus vaccine trial after unexplained illness in U.K.

An independent safety review conducted during what was referred to as a ‘routine action’ to maintain the ‘integrity of the trials’ ended Saturday.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *